文献速递血液透析通路

衰弱与血液透析血管通路建立术后生存及结局的关联

Association of Frailty with Postoperative Survival and Outcomes Following Hemodialysis Vascular Access Creation.
PubMed 文献 · Ann Vasc Surg · 2024-05-28

该单中心回顾性研究分析了2018年8月至2020年11月间200例血管通路手术,发现3年内死亡患者中AVF成熟率低于AVG,且衰弱(改良RAI评分)与3年内死亡风险升高相关;作者认为衰弱或极衰弱患者可能更适合建立AVG而非AVF。

要点

  • 3年内死亡组AVF成熟率65%(22/34)低于AVG的94%(15/16),P=0.03。
  • AVF成熟中位时间69天(IQR 53,87)长于AVG的28天(IQR 18,32),P<0.001。
  • 衰弱患者3年内死亡风险OR 3.74(95%CI 1.82-7.66),极衰弱患者OR 4.20(95%CI 1.95-9.05)。

核心结论

  • 血管通路建立后预期寿命短的患者AVF未成熟率高且成熟时间更长,衰弱或极衰弱患者可能更适合选择AVG而非AVF。

研究设计与样本

  • 单中心回顾性研究,纳入2018年8月至2020年11月期间200例血管通路手术,采用改良衰弱风险分析指数(RAI)评分评估衰弱。

主要发现

  • 3年内死亡组55例(27.5%),其中5例死亡前未随访外科医生;AVF成熟22/34(65%) vs AVG成熟15/16(94%),P=0.03。
  • 已成熟通路中,AVF成熟中位时间69天(IQR 53,87) vs AVG 28天(IQR 18,32),P<0.001。
  • 3年内死亡组年龄70.6岁 vs 63.4岁(P=0.004),BMI 24.8 vs 27.4(P=0.03)。
  • 3年内死亡组心律失常35% vs 15%(P=0.002),COPD 20% vs 10%(P=0.048),通路建立时透析依赖91% vs 75%(P=0.01)。
  • 3年内死亡组衰弱患病率78% vs 49%(P=0.0002);衰弱患者3年内死亡OR 3.74(95%CI 1.82-7.66),极衰弱患者OR 4.20(95%CI 1.95-9.05),均与非衰弱患者比较。

临床怎么用

  • 作者认为,衰弱或极衰弱患者因短期寿命风险高,可能适合建立AVG而非AVF。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The literature suggests that for patients to experience the purported advantages of an arteriovenous fistula (AVF) over arteriovenous graft (AVG), a minimum survival of 18 months is required. With the vascular access guideline shift away from "Fistula First" toward shared decision making, patient survival after vascular access creation is a major factor to consider in optimal access selection. The objective of this study is to examine outcomes of vascular access in patients with short survival and factors associated with short survival, including frailty. METHODS: We performed a retrospective review of 200 access procedures performed between August 2018 and November 2020 at a single institution. Maturation was defined as the date when the surgeon deemed the access ready to be used for dialysis. A modified Risk Analysis Index (RAI) score was used to calculate frailty. RESULTS: Within 3 years after access creation, 55 (27.5%) patients were recorded as dead (mortality within 3 years of access creation [3YMORT]). In the 3YMORT group, 5 did not follow-up with the surgeon prior to death and 22/34 (65%) of AVF versus 15/16 (94%) of AVGs were deemed mature prior to death (P = 0.03). Of the accesses that matured, the median days to maturation for AVF was 69 (interquartile range [IQR] 53, 87) versus 28 (IQR 18, 32) for AVG (P < 0.001). Patients in the 3YMORT group were older (70.6 vs. 63.4, P = 0.004) and had a lower body mass index (24.8 vs. 27.4, P = 0.03). Patients in the 3YMORT group had higher prevalence of dysrhythmia (35% vs. 15%, P = 0.002), chronic obstructive pulmonary disorder (20% vs. 10%, P = 0.048) and dialysis dependence at the time of access creation (91% vs. 75%, P = 0.01). There was no significant difference in sex, white race, Hispanic ethnicity, coronary artery disease, congestive heart failure, previous coronary artery bypass graft or percutaneous coronary intervention, diabetes, hypertension, and peripheral arterial disease between the 2 groups. The 3YMORT group had a significantly higher prevalence of frailty (78% vs. 49%, P = 0.0002). Patients categorized as frail by the RAI had a significantly higher risk of 3YMORT (odds ratio [OR] 3.74, 95% confidence interval [CI] 1.82-7.66) compared to nonfrail patients. Patients categorized as very frail by the RAI had an even higher risk of 3YMORT (OR 4.20, 95% CI 1.95-9.05), compared to nonfrail patients. CONCLUSIONS: Patients with short life expectancy after vascular access creation may have high rates of AVF nonmaturation and longer time to maturation. Factors associated with high risk of mortality within 3 years of vascular access creation correlate well with factors included in the RAI frailty score. Patients who are frail or very frail may be appropriate candidates for AVG creation over AVF considering their high risk for short life expectancy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang KM, Gelabert H, Jimenez JC, et al. Association of Frailty with Postoperative Survival and Outcomes Following Hemodialysis Vascular Access Creation. Ann Vasc Surg. 2024. PMID: 38815906. doi:10.1016/j.avsg.2024.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。